1H NMR based pharmacometabolomics analysis of metabolic phenotype on predicting metabolism characteristics of losartan in healthy volunteers
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 1095, 15-23
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81403086)
- China Postdoctoral Science Foundation (2013M542146)
This publication has 36 references indexed in Scilit:
- The expression level of myocardial β1-adrenergic receptor affects metoprolol antihypertensive effects: A novel mechanism for interindividual differenceMedical Hypotheses, 2013
- Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosisNature Medicine, 2013
- Prevention of systemic and regional haemodynamic alterations, hypercreatininemia, hyperuremia and hyperphosphatemia by losartan in hypertension with acute renal failureActa Physiologica Hungarica, 2011
- Central angiotensin AT1 receptors are involved in metabolic adjustments in response to graded exercise in ratsPeptides, 2009
- Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension studyJournal Of Hypertension, 2009
- Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the ratBMC Research Notes, 2009
- Effect of LDL Cholesterol and Treatment With Losartan on End-Stage Renal Disease in the RENAAL StudyDiabetes Care, 2008
- Regulation of Peroxisome Proliferator–Activated Receptor γ Activity by Losartan MetabolitesHypertension, 2006
- Effect of Losartan on Left Ventricular Diastolic Function in Patients With Nonobstructive Hypertrophic CardiomyopathyThe American Journal of Cardiology, 2005
- Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertensionKidney International, 2001